OBJECTIVE: To assess the frequency, nature, and severity of cardiac abnormalities in limb girdle muscular dystrophy, and its relation to age and weakness in various genotypes. DESIGN: In 26 autosomal dominant, 38 autosomal recessive, and 33 sporadic strictly defined patients with limb girdle muscular dystrophy, cardiac evaluation included history, physical examination, chest x ray, electrocardiography, 24 hour ECG Holter monitoring, and echocardiography. In 35 of the 71 autosomal recessive and sporadic cases muscle biopsies were available for sarcoglycan analysis. MAIN RESULTS: Dilated cardiomyopathy was present in one autosomal dominant case and in three advanced autosomal recessive or sporadic patients, of whom two were found to have alpha sarcoglycan deficiency. Two of these three patients and three other cases showed ECG abnormalities known to be characteristic of the dystrophinopathies. A strong association between the absence of alpha sarcoglycan and the presence of dilated cardiomyopathy was found (p = 0.04). In six autosomal dominant cases there were atrioventricular (AV) conduction disturbances, increasing in severity with age and in concomitant presence of muscle weakness. Pacemaker implantation was necessary in four. CONCLUSIONS: 10% of these patients had clinically relevant cardiac abnormalities. In autosomal dominant limb girdle muscular dystrophy one subtype characterised by muscle weakness and AV conduction disturbances is recognised. In the course of autosomal recessive/sporadic limb girdle muscular dystrophy, dilated cardiomyopathy may develop, probably related to deficiency of dystrophin associated proteins.
OBJECTIVE: To assess the frequency, nature, and severity of cardiac abnormalities in limb girdle muscular dystrophy, and its relation to age and weakness in various genotypes. DESIGN: In 26 autosomal dominant, 38 autosomal recessive, and 33 sporadic strictly defined patients with limb girdle muscular dystrophy, cardiac evaluation included history, physical examination, chest x ray, electrocardiography, 24 hour ECG Holter monitoring, and echocardiography. In 35 of the 71 autosomal recessive and sporadic cases muscle biopsies were available for sarcoglycan analysis. MAIN RESULTS:Dilated cardiomyopathy was present in one autosomal dominant case and in three advanced autosomal recessive or sporadic patients, of whom two were found to have alpha sarcoglycan deficiency. Two of these three patients and three other cases showed ECG abnormalities known to be characteristic of the dystrophinopathies. A strong association between the absence of alpha sarcoglycan and the presence of dilated cardiomyopathy was found (p = 0.04). In six autosomal dominant cases there were atrioventricular (AV) conduction disturbances, increasing in severity with age and in concomitant presence of muscle weakness. Pacemaker implantation was necessary in four. CONCLUSIONS: 10% of these patients had clinically relevant cardiac abnormalities. In autosomal dominant limb girdle muscular dystrophy one subtype characterised by muscle weakness and AV conduction disturbances is recognised. In the course of autosomal recessive/sporadic limb girdle muscular dystrophy, dilated cardiomyopathy may develop, probably related to deficiency of dystrophin associated proteins.
Authors: D A Mascarenhas; D H Spodick; D A Chad; J Gilchrist; P L Townes; U DeGirolami; G H Mudge; D W Maki; R L Bishop Journal: J Am Coll Cardiol Date: 1994-11-01 Impact factor: 24.094
Authors: K Ben Othmane; M Ben Hamida; M A Pericak-Vance; C Ben Hamida; S Blel; S C Carter; A M Bowcock; K Petruhkin; T C Gilliam; A D Roses Journal: Nat Genet Date: 1992-12 Impact factor: 38.330
Authors: S L Roberds; F Leturcq; V Allamand; F Piccolo; M Jeanpierre; R D Anderson; L E Lim; J C Lee; F M Tomé; N B Romero Journal: Cell Date: 1994-08-26 Impact factor: 41.582
Authors: S Noguchi; E M McNally; K Ben Othmane; Y Hagiwara; Y Mizuno; M Yoshida; H Yamamoto; C G Bönnemann; E Gussoni; P H Denton; T Kyriakides; L Middleton; F Hentati; M Ben Hamida; I Nonaka; J M Vance; L M Kunkel; E Ozawa Journal: Science Date: 1995-11-03 Impact factor: 47.728
Authors: C G Bönnemann; R Modi; S Noguchi; Y Mizuno; M Yoshida; E Gussoni; E M McNally; D J Duggan; C Angelini; E P Hoffman Journal: Nat Genet Date: 1995-11 Impact factor: 38.330
Authors: R Bashir; T Strachan; S Keers; A Stephenson; I Mahjneh; G Marconi; L Nashef; K M Bushby Journal: Hum Mol Genet Date: 1994-03 Impact factor: 6.150
Authors: Rajashekar R Gurrala; Venkata Mb Alla; Wilbert S Aronow; Jai S Shankar; Meena K Angamutta; Krishna Lanka; Sundaram Challa; Chandra K Nair Journal: Int J Angiol Date: 2007
Authors: Lisa B Cronk; Bin Ye; Toshihiko Kaku; David J Tester; Matteo Vatta; Jonathan C Makielski; Michael J Ackerman Journal: Heart Rhythm Date: 2006-12-06 Impact factor: 6.343
Authors: R Barresi; C Di Blasi; T Negri; R Brugnoni; A Vitali; G Felisari; A Salandi; S Daniel; F Cornelio; L Morandi; M Mora Journal: J Med Genet Date: 2000-02 Impact factor: 6.318
Authors: Matthew T Wheeler; Michael J Allikian; Ahlke Heydemann; Michele Hadhazy; Sara Zarnegar; Elizabeth M McNally Journal: J Clin Invest Date: 2004-03 Impact factor: 14.808